Developing the science base for reducing tobacco harm.

The University of Minnesota Transdisciplinary Tobacco Use Research Center has been examining the multiple dimensions and the scientific evidence required to determine the feasibility of tobacco harm reduction as a means to reduce tobacco-related mortality and morbidity. Because of the complexity associated with exploring this area, an interdisciplinary approach is necessary. The research components that have been of particular focus at our center include (a) developing and validating biomarkers of tobacco-related exposure and toxicity, (b) developing animal models and designing studies with humans to assess a variety of smoking reduction approaches and potential reduced exposure products, and (c) determining individual differences in response to these interventions and products. A description of the ongoing activities and challenges in these areas is provided, along with projected directions for the future.

[1]  A. Malarcher,et al.  Cigarette Smoking Among Adults in the United States , 2008 .

[2]  D. Hatsukami,et al.  Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial. , 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[3]  S. Siegel,et al.  Translating basic science to improve pharmacotherapy for nicotine dependence. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[4]  D. Hatsukami,et al.  Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[5]  S. Feng,et al.  Short‐Term Clinical Exposure Evaluation of a Second‐Generation Electrically Heated Cigarette Smoking System , 2007, Journal of clinical pharmacology.

[6]  D. Hatsukami,et al.  Smokeless tobacco brand switching: a means to reduce toxicant exposure? , 2007, Drug and alcohol dependence.

[7]  G. Scherer,et al.  Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. , 2007, Regulatory toxicology and pharmacology : RTP.

[8]  M. Thun,et al.  Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco , 2007, Tobacco Control.

[9]  D. Hatsukami,et al.  Effects of high dose transdermal nicotine replacement in cigarette smokers , 2007, Pharmacology Biochemistry and Behavior.

[10]  N. Benowitz,et al.  Determination of phenolic metabolites of polycyclic aromatic hydrocarbons in human urine as their pentafluorobenzyl ether derivatives using liquid chromatography-tandem mass spectrometry. , 2007, Analytical chemistry.

[11]  D. Hatsukami,et al.  Quantitation of an acetaldehyde adduct in human leukocyte DNA and the effect of smoking cessation. , 2007, Chemical research in toxicology.

[12]  M. Utell,et al.  Changes in markers of epithelial permeability and inflammation in chronic smokers switching to a nonburning tobacco device (Eclipse). , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[13]  A. Breland,et al.  Clinical laboratory evaluation of potential reduced exposure products for smokers. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[14]  D. Vallone,et al.  Findings and implications from a national study on potential reduced exposure products (PREPs). , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[15]  L. Weinehall,et al.  Contribution of Swedish moist snuff to the metabolic syndrome: A wolf in sheep's clothing? , 2006, Scandinavian journal of public health.

[16]  Matthew J Carpenter,et al.  Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[17]  D. Hatsukami,et al.  Toxicant Exposure in Cigarette Reducers versus Light Smokers , 2006, Cancer Epidemiology Biomarkers & Prevention.

[18]  A. Tverdal,et al.  Health consequences of reduced daily cigarette consumption , 2006, Tobacco Control.

[19]  D. Hatsukami,et al.  Comparison of Polymorphisms in Genes Involved in Polycyclic Aromatic Hydrocarbon Metabolism with Urinary Phenanthrene Metabolite Ratios in Smokers , 2006, Cancer Epidemiology Biomarkers & Prevention.

[20]  K. Lohr,et al.  Tobacco use: prevention, cessation, and control. , 2006, Evidence report/technology assessment.

[21]  J. Foulds,et al.  Role of snus in initiation and cessation of tobacco smoking in Sweden , 2006, Tobacco Control.

[22]  D. Hatsukami,et al.  Biomarkers to assess the utility of potential reduced exposure tobacco products. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[23]  Stephen S Hecht,et al.  Tobacco-specific nitrosamines in new tobacco products. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[24]  R. Kinser,et al.  Biomarkers of exposure and potential harm in adult smokers of 3–7 mg tar yield (Federal Trade Commission) cigarettes and in adult non-smokers , 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[25]  S. Murphy,et al.  Inactivation of CYP2A6 and CYP2A13 during Nicotine Metabolism , 2006, Journal of Pharmacology and Experimental Therapeutics.

[26]  Josue P. Keely,et al.  Ever users versus never users of a "less risky" cigarette. , 2005, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[27]  Deirdre Lawrence,et al.  Methods to assess potential reduced exposure products. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[28]  P. Sullivan,et al.  Is Swedish snus associated with smoking initiation or smoking cessation? , 2005, Tobacco Control.

[29]  R. Jain,et al.  Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[30]  A. Tverdal,et al.  Health consequences of smoking 1–4 cigarettes per day , 2005, Tobacco Control.

[31]  D. Hatsukami,et al.  Effects of cigarette reduction on cardiovascular risk factors and subjective measures. , 2005, Chest.

[32]  Merete Osler,et al.  Effect of smoking reduction on lung cancer risk. , 2005, JAMA.

[33]  J. Hughes,et al.  The feasibility of smoking reduction: an update. , 2005, Addiction.

[34]  J E Henningfield,et al.  Toward a comprehensive long term nicotine policy , 2005, Tobacco Control.

[35]  E. Weiderpass,et al.  Smokeless tobacco use and risk of cancer of the pancreas and other organs , 2005, International journal of cancer.

[36]  D. Hatsukami,et al.  Hope or hazard? What research tells us about "potentially reduced-exposure" tobacco products , 2005 .

[37]  A. Joseph,et al.  Predictors of smoking reduction without formal intervention. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[38]  R. Tyndale,et al.  Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence , 2005, Clinical pharmacology and therapeutics.

[39]  D. Hatsukami,et al.  Similar Uptake of Lung Carcinogens by Smokers of Regular, Light, and Ultralight Cigarettes , 2005, Cancer Epidemiology Biomarkers & Prevention.

[40]  Neal L. Benowitz,et al.  Metabolism and Disposition Kinetics of Nicotine , 2005, Pharmacological Reviews.

[41]  Å. Westin,et al.  Effects of smoking cessation and reduction in asthmatics. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[42]  R. Kinser,et al.  Short‐Term Exposure Evaluation of Adult Smokers Switching From Conventional to First‐Generation Electrically Heated Cigarettes During Controlled Smoking , 2005, Journal of clinical pharmacology.

[43]  E. Gilpin,et al.  The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[44]  Richard Doll,et al.  Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.

[45]  D. Hatsukami,et al.  Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. , 2004, Journal of the National Cancer Institute.

[46]  J. Hughes,et al.  Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. , 2004, Journal of consulting and clinical psychology.

[47]  R. Krueger,et al.  Community tobacco control leaders’ perceptions of harm reduction , 2004, Tobacco Control.

[48]  P. Lantz,et al.  Tobacco harm reduction: what do the experts think? , 2004, Tobacco Control.

[49]  S. Hecht,et al.  Smoking behaviour and toxin exposure during six weeks use of a potential reduced exposure product: Omni , 2004, Tobacco Control.

[50]  D. Hatsukami,et al.  Effects of reduced cigarette smoking on levels of 1-hydroxypyrene in urine. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[51]  D. Hatsukami,et al.  Characteristics of cigarette smokers seeking treatment for cessation versus reduction. , 2004, Addictive behaviors.

[52]  K. Haustein,et al.  Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT). , 2004, International journal of clinical pharmacology and therapeutics.

[53]  M. Thun,et al.  Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8 , 2004, BMJ : British Medical Journal.

[54]  A. Nissinen,et al.  Cardiovascular risk factors as determinants of 25-year all-cause mortality in the seven countries study , 2004, European Journal of Epidemiology.

[55]  M. Fiore,et al.  Transdisciplinary science applied to the evaluation of treatments for tobacco use. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[56]  D. Jerina,et al.  r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in human urine: a potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[57]  K. Fagerström,et al.  Effect of smokeless tobacco (snus) on smoking and public health in Sweden , 2003, Tobacco control.

[58]  Michael J Thun,et al.  Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: results from Cancer Prevention Study II. , 2003, Cancer research.

[59]  A. Breland,et al.  Tobacco specific nitrosamines and potential reduced exposure products for smokers: a preliminary evaluation of Advance™ , 2003, Tobacco control.

[60]  M. Lesage,et al.  Effects of continuous nicotine infusion on nicotine self-administration in rats: relationship between continuously infused and self-administered nicotine doses and serum concentrations , 2003, Psychopharmacology.

[61]  D. Burns Epidemiology of smoking-induced cardiovascular disease. , 2003, Progress in cardiovascular diseases.

[62]  Mary Ellen Wewers,et al.  Distribution of daily smokers by stage of change: Current Population Survey results. , 2003, Preventive medicine.

[63]  J. Vestbo,et al.  Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976–1998: a pooled cohort study , 2003, Journal of epidemiology and community health.

[64]  K. Warner,et al.  Hardening and the hard-core smoker: concepts, evidence, and implications. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[65]  K. Fagerström,et al.  Long-term effects of the Eclipse cigarette substitute and the nicotine inhaler in smokers not interested in quitting. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[66]  A. Breland,et al.  Evaluating acute effects of potential reduced-exposure products for smokers: clinical laboratory methodology. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[67]  J. Vestbo,et al.  Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from The Copenhagen Centre for Prospective Population Studies. , 2002, American journal of epidemiology.

[68]  B. Bombick,et al.  Relationship between FTC 'tar' and urine mutagenicity in smokers of tobacco-burning or Eclipse cigarettes. , 2002, Mutation research.

[69]  James R. Anderson,et al.  Evaluation of subclinical respiratory tract inflammation in heavy smokers who switch to a cigarette-like nicotine delivery device that primarily heats tobacco. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[70]  Å. Westin,et al.  Influence of long-term smoking reduction on health risk markers and quality of life. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[71]  J. Vestbo,et al.  Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study , 2002, Thorax.

[72]  S. Hecht,et al.  Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. , 2002, Carcinogenesis.

[73]  M. Lesage,et al.  Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine , 2002, Pharmacology Biochemistry and Behavior.

[74]  S. Hecht,et al.  Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. , 2002, Chemical research in toxicology.

[75]  R. Tyndale,et al.  Genetic Variation in CYP2A6-Mediated Nicotine Metabolism Alters Smoking Behavior , 2002, Therapeutic drug monitoring.

[76]  S. Shiffman,et al.  Smokers' beliefs about “Light” and “Ultra Light” cigarettes , 2001, Tobacco control.

[77]  Å. Westin,et al.  Effect of smoking reduction and cessation on cardiovascular risk factors. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[78]  T. Eissenberg,et al.  Withdrawal-suppressing effects of a novel smoking system: comparison with own brand, not own brand, and de-nicotinized cigarettes. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[79]  R. Wallace,et al.  Clearing the smoke: assessing the science base for tobacco harm reduction. , 2001 .

[80]  J. Gitchell,et al.  cigarettes Smokers ' beliefs about ' ' Light ' ' and ' ' Ultra Light ' ' , 2001 .

[81]  K. Fagerström,et al.  Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit , 2000, Tobacco control.

[82]  N. Benowitz,et al.  Effects of cigarette smoking and carbon monoxide on nicotine and cotinine metabolism , 2000, Clinical pharmacology and therapeutics.

[83]  T. Eissenberg,et al.  Preliminary evaluation of a novel smoking system: effects on subjective and physiological measures and on smoking behavior. , 2000, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[84]  E. Perez-stable,et al.  Ethnic differences in N-glucuronidation of nicotine and cotinine. , 1999, The Journal of pharmacology and experimental therapeutics.

[85]  N. Benowitz,et al.  Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. , 1998, The Journal of pharmacology and experimental therapeutics.

[86]  R. MacCoun Toward a psychology of harm reduction. , 1998, The American psychologist.

[87]  M. Eriksson,et al.  Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case‐control study , 1998, International journal of cancer.

[88]  H. Johansson,et al.  Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck , 1998, Cancer.

[89]  K. Fagerström,et al.  Nicotine replacement: a new approach to reducing tobacco-related harm. , 1998, The European respiratory journal.

[90]  J E Henningfield,et al.  Tobacco dependence treatments: review and prospectus. , 1998, Annual review of public health.

[91]  T V Perneger,et al.  Distributions of smokers by stage: international comparison and association with smoking prevalence. , 1997, Preventive medicine.

[92]  D. Hatsukami,et al.  Society for Research on Nicotine and Tobacco. , 1997, Addiction.

[93]  B. Bombick,et al.  Human urine mutagenicity study comparing cigarettes which burn or primarily heat tobacco. , 1996, Mutation research.

[94]  J. Henningfield Introduction to tobacco harm reduction as a complementary strategy to smoking cessation , 1995, Tobacco Control.

[95]  J. Hughes Applying harm reduction to smoking , 1995, Tobacco Control.

[96]  M. Thun,et al.  Excess mortality among cigarette smokers: changes in a 20-year interval. , 1995, American journal of public health.

[97]  G. Giovino,et al.  Smokeless tobacco brand preference and brand switching among US adolescents and young adults , 1995 .

[98]  J. Manson,et al.  Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. , 1994, Archives of internal medicine.

[99]  N. Benowitz,et al.  Establishing a nicotine threshold for addiction. The implications for tobacco regulation. , 1994, The New England journal of medicine.

[100]  N. Benowitz,et al.  Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers , 1993, Clinical pharmacology and therapeutics.

[101]  A. Auquier,et al.  Changes in patterns of cigarette smoking and lung cancer risk: results of a case-control study. , 1989, British Journal of Cancer.

[102]  F. Berrino,et al.  Modifying risk of developing lung cancer by changing habits of cigarette smoking. , 1984, British medical journal.

[103]  E. Wynder,et al.  Impact of long-term filter cigarette usage on lung and larynx cancer risk: a case-control study. , 1979, Journal of the National Cancer Institute.

[104]  R. Doll,et al.  Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. , 1978, Journal of epidemiology and community health.